Invesco Ltd. Cytek Biosciences, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 332,905 shares of CTKB stock, worth $1.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

332,905

Previous 320,471 3.88%

Holding current value

$1.71 Million

Previous $1.79 Million 3.13%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$4.73 - $6.73 $58,812 - $83,680	12,434 Added 3.88%	332,905 $1.84 Million
Q2 2024 Aug 13, 2024	SELL	$5.3 - $6.91 $166,276 - $216,787	-31,373 Reduced 8.92%	320,471 $1.79 Million
Q1 2024 May 14, 2024	BUY	$6.29 - $9.15 $165,018 - $240,050	26,235 Added 8.06%	351,844 $2.36 Million
Q4 2023 Feb 12, 2024	SELL	$4.1 - $9.51 $270,936 - $628,439	-66,082 Reduced 16.87%	325,609 $2.97 Million
Q3 2023 Nov 13, 2023	BUY	$5.52 - $9.5 $105,680 - $181,877	19,145 Added 5.14%	391,691 $2.16 Million
Q2 2023 Aug 11, 2023	BUY	$6.69 - $11.99 $1.67 Million - $3 Million	250,243 Added 204.61%	372,546 $3.18 Million
Q1 2023 May 12, 2023	BUY	$8.44 - $13.47 $624,492 - $996,672	73,992 Added 153.16%	122,303 $1.12 Million
Q4 2022 Feb 13, 2023	SELL	$9.71 - $15.86 $46,277 - $75,588	-4,766 Reduced 8.98%	48,311 $493,000
Q3 2022 Nov 14, 2022	BUY	$10.96 - $15.45 $4,559 - $6,427	416 Added 0.79%	53,077 $781,000
Q2 2022 Aug 15, 2022	BUY	$7.41 - $11.56 $93,077 - $145,205	12,561 Added 31.32%	52,661 $565,000
Q1 2022 May 16, 2022	BUY	$9.89 - $17.25 $396,589 - $691,725	40,100 New	40,100 $432,000

Others Institutions Holding CTKB

# of Institutions

134

Shares Held

72.2M

Call Options Held

400

Put Options Held

View Full List

About Cytek Biosciences, Inc.

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $693M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

More about CTKB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account